- Home
- ORKT vs CPIX Comparison
ORKT vs CPIX Comparison
Compare ORKT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKT
- CPIX
- Stock Information
- Founded
- ORKT 2003
- CPIX 1999
- Country
- ORKT Singapore
- CPIX United States
- Employees
- ORKT N/A
- CPIX N/A
- Industry
- ORKT
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ORKT
- CPIX Health Care
- Exchange
- ORKT NYSE
- CPIX Nasdaq
- Market Cap
- ORKT N/A
- CPIX 40.1M
- IPO Year
- ORKT 2024
- CPIX 2009
- Fundamental
- Price
- ORKT $0.79
- CPIX $3.04
- Analyst Decision
- ORKT Strong Buy
- CPIX
- Analyst Count
- ORKT 1
- CPIX 0
- Target Price
- ORKT $5.00
- CPIX N/A
- AVG Volume (30 Days)
- ORKT 313.1K
- CPIX 113.7K
- Earning Date
- ORKT 01-01-0001
- CPIX 08-05-2025
- Dividend Yield
- ORKT N/A
- CPIX N/A
- EPS Growth
- ORKT N/A
- CPIX N/A
- EPS
- ORKT N/A
- CPIX N/A
- Revenue
- ORKT $2,962,282.00
- CPIX $41,083,299.00
- Revenue This Year
- ORKT $9.63
- CPIX N/A
- Revenue Next Year
- ORKT N/A
- CPIX N/A
- P/E Ratio
- ORKT N/A
- CPIX N/A
- Revenue Growth
- ORKT N/A
- CPIX 5.82
- 52 Week Low
- ORKT $0.40
- CPIX $1.04
- 52 Week High
- ORKT $8.00
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- ORKT N/A
- CPIX 41.13
- Support Level
- ORKT N/A
- CPIX $3.00
- Resistance Level
- ORKT N/A
- CPIX $3.76
- Average True Range (ATR)
- ORKT 0.00
- CPIX 0.53
- MACD
- ORKT 0.00
- CPIX -0.02
- Stochastic Oscillator
- ORKT 0.00
- CPIX 27.95
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.